Understanding how a specific protein helps cells survive and function properly
Elucidating the Mechanistic Details of the Grp94 Molecular Chaperone through an Integrated Computational and Experimental Approach
This study is looking at a protein called Grp94 that helps other proteins fold correctly in our cells, which is important because when proteins don’t fold right, it can lead to serious health problems like diabetes and cancer, and the researchers hope their findings will help create better treatments for these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Miami University Oxford NIH-funded |
| Lab location | 1 site (Oxford, United States) |
| Project ID | NIH-10876394 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called Grp94, which is essential for proper protein folding within cells. By using both computational and experimental methods, the team aims to uncover the mechanisms by which Grp94 operates, particularly in the endoplasmic reticulum. This understanding is crucial because misfolded proteins can lead to serious health issues, including diabetes, cancer, and neurodegenerative diseases. The findings could pave the way for new drug designs that target these diseases more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from conditions related to protein misfolding, such as type 2 diabetes, certain cancers, or neurodegenerative disorders.
Not a fit: Patients with conditions unrelated to protein misfolding or those who do not have any of the target diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases caused by protein misfolding, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in targeting similar chaperone proteins for therapeutic purposes, indicating a potential for success in this area.
Where this research is happening
Oxford, United States
- Miami University Oxford — Oxford, United States (Active)
Researchers
- Principal investigator: Kravats, Andrea N — Miami University Oxford
- Study coordinator: Kravats, Andrea N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.